MEI Pharma Statistics

Total Valuation

MEI Pharma has a market cap or net worth of $16.66 million. The enterprise value is -$10.25 million.

Market Cap	16.66M
Enterprise Value	-10.25M

Important Dates

The next estimated earnings date is Tuesday, February 11, 2025, after market close.

Earnings Date	Feb 11, 2025
Ex-Dividend Date	n/a

Share Statistics

MEI Pharma has 6.66 million shares outstanding.

Current Share Class	6.66M
Shares Outstanding	6.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.46%
Owned by Institutions (%)	16.58%
Float	4.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.67
P/TBV Ratio	0.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.66

Current Ratio	9.66
Quick Ratio	9.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -87.73% and return on invested capital (ROIC) is -36.42%.

Return on Equity (ROE)	-87.73%
Return on Assets (ROA)	-33.49%
Return on Capital (ROIC)	-36.42%
Revenue Per Employee	n/a
Profits Per Employee	-$1.66M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.51% in the last 52 weeks. The beta is 0.64, so MEI Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-60.51%
50-Day Moving Average	2.83
200-Day Moving Average	3.10
Relative Strength Index (RSI)	31.69
Average Volume (20 Days)	25,037

Short Selling Information

The latest short interest is 48,934, so 0.73% of the outstanding shares have been sold short.

Short Interest	48,934
Short Previous Month	63,464
Short % of Shares Out	0.73%
Short % of Float	0.99%
Short Ratio (days to cover)	0.94

Income Statement

Revenue	n/a
Gross Profit	-14.38M
Operating Income	-34.56M
Pretax Income	26.16M
Net Income	-46.60M
EBITDA	-33.90M
EBIT	-34.56M
Earnings Per Share (EPS)	-$6.99

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	26.91M
Total Debt	n/a
Net Cash	26.91M
Net Cash Per Share	$4.04
Equity (Book Value)	24.88M
Book Value Per Share	3.73
Working Capital	24.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.43 million and capital expenditures -$7,000, giving a free cash flow of -$43.44 million.

Operating Cash Flow	-43.43M
Capital Expenditures	-7,000
Free Cash Flow	-43.44M
FCF Per Share	-$6.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MEI Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-279.78%
FCF Yield	-260.78%

Dividend Details

Analyst Forecast

The average price target for MEI Pharma is $7.00, which is 180.00% higher than the current price. The consensus rating is "Hold".

Price Target	$7.00
Price Target Difference	180.00%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 17, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 17, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

MEI Pharma has an Altman Z-Score of -16.96 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-16.96
Piotroski F-Score	1